The mechanism of action of heterologous anti-lymphocyte sera. I. "In vitro" activity and their effects on different aspects of immunity in rats.
D000372:Agglutination Tests; D000818:Animals; D000918:Antibody Specificity; D000961:Antilymphocyte Serum / Q000494:pharmacology*; D002351:Carrageenan; D002462:Cell Membrane / Q000276:immunology; D002464:Cell Migration Inhibition; D004487:Edema; D006084:Graft Rejection / Q000187:drug effects*; D007109:Immunity / Q000187:drug effects*; D007111:Immunity, Cellular / Q000187:drug effects; D007165:Immunosuppression Therapy; D007249:Inflammation; D008213:Lymphocyte Activation; D009698:Nucleoproteins; D011817:Rabbits; D051381:Rats; D012756:Sheep; D016038:Skin Transplantation; D013950:Thymus Gland / Q000166:cytology / Q000276:immunology*; D014184:Transplantation, Homologous
D000961:Antilymphocyte Serum; D009698:Nucleoproteins; D002351:Carrageenan